Tarzena Capsules 0.25mg, from Pfizer, contains Talazoparib (YJ code: 4291081M2029, standard: 0.25mg 1 capsule). As a poly ADP-ribose polymerase (PARP) inhibitor, it is used for advanced breast cancer with germline BRCA mutations and homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer, by inhibiting PARP1/2 and leading to DNA damage accumulation in cancer cells.
Tarzena Capsules 0.25mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
